Pain, Sedation, Pharmacology, Interactions, and PONV
Key Takeaways
- Pain assessment in perianesthesia care includes intensity, location, quality, function, expected surgical pain, sedation level, respiratory status, and response to intervention.
- After IV opioids, reassess pain, sedation, respiratory rate, oxygenation, and ventilation within a short interval; oversedation is a safety problem even when pain improves.
- PONV risk rises with female sex, history of PONV or motion sickness, nonsmoking status, volatile anesthetics, nitrous oxide, postoperative opioids, and certain procedures.
- Rescue antiemetic treatment generally uses a different drug class than prophylaxis and is paired with hydration, pain control, minimized opioids, and readiness to delay discharge.
Pain Control Without Losing Safety
Pain is expected after many procedures, but uncontrolled pain is not benign. It worsens hypertension, tachycardia, splinting, delayed ambulation, nausea, anxiety, and discharge readiness. At the same time, aggressive opioid dosing can cause oversedation, airway obstruction, hypoventilation, nausea, pruritus, urinary retention, and falls.
CAPA questions often ask for the best next action when pain remains high after medication. The answer is usually reassessment and clinical reasoning, not automatic repeat dosing. Reassess the pain score, surgical site, vital signs, sedation level, respiratory status, medication timing, allergies, regional block status, and whether the pain quality suggests a complication.
Multimodal Analgesia
Multimodal analgesia uses different mechanisms to reduce pain and opioid exposure. Depending on procedure and orders, this may include acetaminophen, nonsteroidal anti-inflammatory drugs when safe, local infiltration, peripheral nerve blocks, neuraxial techniques, ice/elevation, splinting, positioning, and small titrated opioid doses.
| Intervention | Nursing Monitoring Point |
|---|---|
| IV opioid | Respiratory rate, sedation score, SpO2, EtCO2 if used, BP, nausea, pruritus |
| Regional block | Motor/sensory level, limb protection, fall risk, local anesthetic toxicity symptoms |
| NSAID/ketorolac | Bleeding risk, renal function, allergy/asthma history, surgeon restrictions |
| Acetaminophen | Total daily dose, liver disease, combination opioid products |
| PCA pump | Correct settings, patient-only dosing, sedation/respiratory status, pump function |
Pain and Sedation Reassessment
After IV opioid administration, reassessment is typically done within minutes rather than at the next routine vital-sign cycle. Many facilities use a 5- to 15-minute reassessment interval for IV analgesics and a longer interval for oral medications. The exact policy may vary, but the exam principle is consistent: pain relief must be paired with sedation and respiratory reassessment.
A patient who reports pain 3/10 but is difficult to arouse with RR 8/min is not successfully managed. The priority is airway, stimulation, oxygenation/ventilation assessment, holding further sedating medication, notifying the provider, and preparing reversal if ordered. Naloxone reverses opioid effects but can also abruptly return severe pain and sympathetic stimulation, so it is titrated according to protocol.
Sedatives and Reversal Agents
Benzodiazepines, opioids, propofol, antihistamines, gabapentinoids, alcohol, sleep medications, and some antiemetics can compound sedation. Older adults and patients with OSA, obesity hypoventilation, chronic lung disease, renal disease, or hepatic dysfunction are more vulnerable.
Naloxone reverses opioid-induced respiratory depression. Flumazenil reverses benzodiazepine effects but can precipitate seizures in patients with benzodiazepine dependence, certain overdoses, or seizure disorders. Reversal does not end monitoring; resedation can occur when the reversal agent wears off before the original medication.
PONV Risk and Prevention
Postoperative nausea and vomiting (PONV) is more than discomfort in ambulatory care. It can cause dehydration, wound stress, bleeding risk, aspiration risk, unplanned admission, and delayed return to oral intake. Risk assessment begins before surgery and continues in recovery.
Common adult risk factors include:
- Female sex
- History of PONV or motion sickness
- Nonsmoking status
- Younger age
- Volatile anesthetics or nitrous oxide exposure
- Postoperative opioid use
- Longer anesthetic duration
- Certain procedures, including laparoscopic, gynecologic, ENT, and eye procedures
Risk reduction includes adequate hydration, opioid-sparing analgesia, regional anesthesia when appropriate, propofol-based approaches when selected by anesthesia, and prophylactic antiemetics such as 5-HT3 antagonists, dexamethasone, dopamine antagonists, anticholinergics, or NK1 antagonists depending on patient factors and orders.
Treating PONV in Recovery
If a patient received ondansetron prophylaxis and vomits in Phase II, simply repeating the same class too soon may be less effective than using a different ordered class. Nursing actions include protecting the airway, positioning safely, assessing hydration and pain, reducing triggering movement or odors, checking medication timing, administering ordered rescue therapy, and reassessing before discharge.
A patient should not be discharged with uncontrolled nausea, repeated vomiting, inability to retain fluids when required by procedure policy, orthostatic symptoms, or excessive sedation from rescue medications. Postdischarge nausea and vomiting matters too; instructions should include hydration, diet progression, medication timing, and when to call.
A patient received IV hydromorphone 10 minutes ago. Pain decreased from 8/10 to 4/10, but the patient is difficult to arouse and has RR 7/min. What is the priority?
Which ambulatory patient has the highest PONV risk profile?